WU Li,WEN Xiao-ping,HUAN Wei.Treatment of primany hepatic carcinoma with three-dimensional conformal radiation therapy combined with transcatheter arterial chemoembolization[J].Chinese Journal of Radiological Medicine and Protection,2006,26(3):256-258
Treatment of primany hepatic carcinoma with three-dimensional conformal radiation therapy combined with transcatheter arterial chemoembolization
Received:February 28, 2006  
DOI:
KeyWords:Liver neoplasms/radiotherapy  Radiotherapy,conformal  Liver neoplasms/chemotherapy  Embolization,therapeutic  Infusion,therapeutic
FundProject:
Author NameAffiliation
WU Li Department of Oncology, Attached Hospital of Guiyang Medical College, Guiyang 550004, China 
WEN Xiao-ping Department of Oncology, Attached Hospital of Guiyang Medical College, Guiyang 550004, China 
HUAN Wei Department of Oncology, Attached Hospital of Guiyang Medical College, Guiyang 550004, China 
Hits: 2436
Download times: 1910
Abstract::
      Objective To evaluate the effects of three-dimensional conformal radiation therapy (3DCRT) combined with transcatheter arterial chemoembolization (TACE) on stage Ⅲ/Ⅳ primary hepatic carcinoma. Methods Eighty cases of stage Ⅲ/Ⅳ primary hepatic carcinoma were randomly divided into two groups: 40 cases treated with three-dimensional conformal radiation therapy combined with transcatheter arterial chemoembolization (3DCRT+TACE group) and 40 cases treated with three-dimensional conformal radiation therapy associated with hepatic arterial infusion chemotherapy (3DCRT+HAI group). Results The response rates were 75% and 45% in 3DCRT+TACE group and 3DCRT+HAI group, respectively; and the difference between the two groups was statistically significant (P<0.05). The 0.5-, 1-, and 2-year local response rates were 93%, 85% and 61% in 3DCRT+TACE group, and 70%, 43% and 33% in 3DCRT+HAI group, respectively; and the difference between the two groups was statistically significant (P<0.05). The difference of distant metastasis rates, 30% in 3DCRT+TACE group and 38% in 3DCRT+HAI group, was not statistically significant (P>0.05), The 0.5-, 1- and 2-year survival rates were 73%, 45% and 28% in 3DCRT+TACE group, and 45%, 25% and 13% in 3DCRT+HAI group, respectively; and the difference between the two groups was statistically significant (P<0.01). The difference of side-effect rates between the two groups was not statistically significant (P>0.05). Conclusion Three-dimensional conformal radiation therapy combined with transcatheter arterial chemoembolization improved prognosis of stage Ⅲ/Ⅳ primary hepatic carcinoma.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:12029581  On-line:0

v
Scan QR Code
&et=90A12E02A57D426A2D8C831B2FE67B573198284A423EBD60AD3695CEB7A185F73105F7E6317635E20262AC2C3E3FFFB4665402B3C70E61639B4DA99823EBAF5EF4D6CECA0A2F5A90F53AEC1BF52F0181804B7AECF7565A258E315B28DC4735C69BF080D27DD2E8B1EB5E93470932574D9EA749AB9AFC8BAE35DAD9D92D6049610A76F137FDBB7ABD196895996A3C4E6A40BDD3B3ECEFE100&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=37904DC365DD7266&aid=9BDE2CF3E4F095FC&vid=&iid=38B194292C032A66&sid=80BD0A2EF8664214&eid=B799C1769FCACDC8&fileno=20060319&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="37904DC365DD7266"; var my_aid="9BDE2CF3E4F095FC";